<DOC>
	<DOCNO>NCT01540994</DOCNO>
	<brief_summary>The purpose study evaluate short course ( five radiation treatment ) focus ( `` stereotactic '' ) external beam radiation therapy treatment early stage prostate cancer .</brief_summary>
	<brief_title>Stereotactic Body Radiation Therapy ( SBRT ) Prostate Cancer</brief_title>
	<detailed_description>External beam radiation therapy prostate cancer , effective , take 9 week deliver Monday Friday basis . Recent phase I/II study Seattle Palo Alto use stereotactic guidance deliver high dos radiation prostate 1 2 week period time suggest outcome may equal superior standard approach . These data , combine markedly improve convenience patient , make radiosurgery ( SBRT ) early-stage prostate cancer entice option . The goal study offer radiosurgical option patient within Sharp system umbrella IRB-approved study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male age ( typically 50 70 year old ) low risk disease . This define Gleason 's score 6 less , clinical stage T2a le , PSA le 15 . We also include patient Gleason 's score 3+4=7 few 2 core positive , 5mm tumor aggregate dimension . Prior surgery radiotherapy prostate cancer , PSA 10 , Gleason score 7 , 8 , 9 , 10 ( except Gleason 7 note , ) , clinical stage T2b , T2c , T3 , T4 .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Neoplasms</keyword>
	<keyword>Urogenital neoplasm</keyword>
	<keyword>Genital neoplasm , male</keyword>
</DOC>